| Rank | Holder | SharesFloat % | Change | Date reported |
|---|---|---|---|---|
| 1 | Qvt Financial LP | 65.79M (17.76%) | 0.00 Increased by 0.00% | Dec 31, 24 |
| 2 | SB INVESTMENT ADVISERS (UK) LTD | 62.06M (16.75%) | -3.88M Decreased by -6.25% | Dec 31, 24 |
| 3 | FMR Inc | 49.30M (13.30%) | 156.53K Increased by +0.32% | Dec 31, 24 |
| 4 | Viking Global Investors LP | 47.81M (12.90%) | -6.29M Decreased by -13.15% | Dec 31, 24 |
| 5 | Vanguard Group Inc | 44.09M (11.90%) | 2.40M Increased by +5.45% | Dec 31, 24 |
| 6 | BlackRock Inc | 42.16M (11.38%) | 195.47K Increased by +0.46% | Dec 31, 24 |
| 7 | Morgan Stanley - Brokerage Accounts | 34.62M (9.34%) | 4.94M Increased by +14.27% | Dec 31, 24 |
| 8 | State Street Corp | 20.80M (5.61%) | 1.24M Increased by +5.96% | Dec 31, 24 |
| 9 | Rubric Capital Management LP | 20.00M (5.40%) | -2.40M Decreased by -12.00% | Dec 31, 24 |
| 10 | State Street Corporation | 17.15M (4.63%) | 3.43M Increased by +19.97% | Mar 31, 24 |
| 11 | Wellington Management Company LLP | 13.64M (3.68%) | -1.20M Decreased by -8.82% | Dec 31, 23 |
| 12 | Patient Square Capital | 12.48M (3.37%) | 251.53K Increased by +2.02% | Dec 31, 24 |
| 13 | T. Rowe Price Investment Management,Inc. | 10.65M (2.87%) | 10.65M Increased by +100.00% | Sep 30, 23 |
| 14 | Two Seas Capital LP | 10.17M (2.74%) | 442.91K Increased by +4.36% | Dec 31, 24 |
| 15 | Amvescap Plc. | 9.52M (2.57%) | 3.16M Increased by +33.21% | Dec 31, 24 |
| 16 | Geode Capital Management, LLC | 7.77M (2.10%) | 26.73K Increased by +0.34% | Dec 31, 24 |
| 17 | Baker Bros Advisors LP | 7.41M (2.00%) | -179.19K Decreased by -2.42% | Mar 31, 24 |
| 18 | Farallon Capital Management, L.L.C. | 7.34M (1.98%) | 3.48M Increased by +47.47% | Dec 31, 23 |
| 19 | Woodline Partners LP | 6.13M (1.65%) | -2.55M Decreased by -41.66% | Dec 31, 24 |
| 20 | Citadel Advisors Llc | 5.93M (1.60%) | 4.00M Increased by +67.54% | Sep 30, 24 |
| Rank | Holder | SharesFloat % | Change | Date reported |
|---|---|---|---|---|
| 1 | Fidelity Growth Compy Commingled Pl S | 23.04M (6.22%) | 643.40K Increased by +2.79% | Jan 31, 25 |
| 2 | Fidelity Growth Compy Commingled Pl O | 21.15M (5.71%) | 439.20K Increased by +2.08% | Aug 31, 24 |
| 3 | Fidelity Growth Company Fund | 16.29M (4.40%) | 520.50K Increased by +3.20% | Jan 31, 25 |
| 4 | Vanguard Total Stock Mkt Idx Inv | 14.84M (4.00%) | 8.66K Increased by +0.06% | Feb 28, 25 |
| 5 | iShares Core S&P Mid-Cap ETF | 13.96M (3.77%) | 10.49K Increased by +0.08% | Feb 28, 25 |
| 6 | Vanguard Small Cap Index | 12.08M (3.26%) | 9.87K Increased by +0.08% | Feb 28, 25 |
| 7 | Fidelity® Growth Company | 10.84M (2.93%) | 288.60K Increased by +2.66% | Nov 30, 23 |
| 8 | Vanguard Health Care Inv | 9.57M (2.58%) | 0.00 Increased by 0.00% | Dec 31, 23 |
| 9 | SPDR® S&P Biotech ETF | 7.59M (2.05%) | -46.10K Decreased by -0.61% | Feb 28, 25 |
| 10 | Invesco S&P MidCap Quality ETF | 6.89M (1.86%) | -1.14K Decreased by -0.02% | Feb 28, 25 |
| 11 | Vanguard Small Cap Growth Index Inv | 6.79M (1.83%) | -35.01K Decreased by -0.52% | Feb 28, 25 |
| 12 | Vanguard Institutional Extnd Mkt Idx Tr | 6.50M (1.76%) | 18.64K Increased by +0.29% | Feb 28, 25 |
| 13 | Fidelity Growth Company K6 | 5.26M (1.42%) | 199.50K Increased by +3.79% | Jan 31, 25 |
| 14 | T. Rowe Price Mid-Cap Growth | 5.25M (1.42%) | 5.25M Increased by +100.00% | Sep 30, 23 |
| 15 | T. Rowe Price US Mid-Cap Growth Equity | 5.25M (1.42%) | 5.25M Increased by +100.00% | Sep 30, 23 |
| 16 | Fidelity® Select Biotechnology | 4.60M (1.24%) | 61.10K Increased by +1.33% | Nov 30, 23 |
| 17 | Fidelity Series Growth Company | 4.15M (1.12%) | 422.80K Increased by +10.18% | Jan 31, 25 |
| 18 | MS INVF US Advantage I | 3.77M (1.02%) | 0.00 Increased by 0.00% | Dec 31, 24 |
| 19 | Morgan Stanley Growth | 3.76M (1.01%) | 317.97K Increased by +8.46% | Dec 31, 24 |
| 20 | Morgan Stanley Growth SMA | 3.76M (1.01%) | 317.97K Increased by +8.46% | Dec 31, 24 |